Impact on Outcomes of Human Leukocyte AntigenMatching by Allele-Level Typing in Adults withAcute Myeloid Leukemia Undergoing Umbilical CordBlood Transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 1, 2014, Pages 106-110

  Sanz, Jaime ^a   Jaramillo, Francisco J ^a   Planelles, Dolores ^a   Montesinos, Pau ^a   Lorenzo, Ignacio ^a   Moscardó, Federico ^a   Martin, Guillermo ^a   López, Francisca ^a   Martínez, Jesús ^a   Jarque, Isidro ^a   de la Rubia, Javier ^a   Larrea, Luis ^a   Sanz, Miguel A ^a   Sanz, Guillermo F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute myeloid leukemia; Human leukocyte antigen (HLA); Umbilical cord blood

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA TYPING; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELOABLATIVE AGONISTS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84890909694     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.10.016     Document Type: Article

References (27)

1. Eapen M., Rubinstein P., Zhang M.-J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007, 369:1947-1954.
2. Kurtzberg J., Prasad V.K., Carter S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008, 112:4318-4327.
3. Barker J.N., Scaradavou A., Stevens C.E. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 2010, 115:1843-1849.
4. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors. NEngl J Med 1998, 339:1565-1577.
5. Stevens C.E., Carrier C., Carpenter C., et al. HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood 2011, 118:3969-3978.
6. Atsuta Y., Kanda J., Takanashi M., et al. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica 2013, 98:814-822.
7. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
8. Sanz J., Montesinos P., Saavedra S., et al. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 2010, 16:1589-1595.
9. Sanz J., Boluda J.C.H., Martín C., et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone Marrow Transplant 2012, 47:1287-1293.
10. Sanz G.F., Saavedra S., Planelles D., et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001, 98:2332-2338.
11. Cheson B.D., Bennett J.M., Kopecky K.J. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in acute myeloid leukemia. JClin Oncol 2003, 21:4642-4649.
12. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
13. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
14. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
15. Willemze R., Rodrigues C.A., Labopin M., et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 2009, 23:492-500.
16. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
17. Gray R.J. Aclass of K-sample tests for comparing the cumulative incidence of a competing risk. Annals Statistics 1988, 16:1141-1154.
18. Kaplan E.L., Meier P. Nonparametric Estimation from Incomplete Observations. JAm Statistical Assoc 1958, 53:457-481.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
20. Cox D.R. Regression models and life tables (with discussion). JR Stat Soc B 1972, 34:187-220.
21. Fine J.P., Gray R.J. Aproportional hazards model for the subdistribution of a competing risk. JAm Statistical Assoc 1999, 94:496-509.
22. R Core Team R: A language and environment for statistical computing 2012, The R Foundation for Statistical Computing, Vienna, Austria.
23. Cohen Y.C., Scaradavou A., Stevens C.E., et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant 2011, 46:70-76.
24. Arcese W., Rocha V., Labopin M., et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006, 91:223-230.
25. Kanda J., Atsuta Y., Wake A., et al. Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Biol Blood Marrow Transplant 2013, 19:247-254.
26. Matsuno N., Wake A., Uchida N., et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 2009, 114:1689-1695.
27. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004, 32:397-407.